Latest Options News

xReality Group’s US subsidiary Operator XR has landed its largest order yet, a $5.7 million contract to supply VR training systems to the Texas Department of Public Safety, marking a significant milestone in its US expansion.

AMP Limited has announced an ordinary dividend of AUD 0.02 per share for the six months ending June 2025, with a 20% franking credit, payable in late September.

Prophecy International and Complexica announce a strategic merger to form MergeCo, an ASX-listed AI pure play with enhanced scale, product synergies, and growth potential.

Prophecy International Holdings has agreed to acquire Complexica in a transformative merger, creating Complexica Group Limited, an ASX-listed AI pure play software company with enhanced scale and growth potential.

EOS has landed a landmark €71.4 million export contract for its 100kW High Energy Laser Weapon system, marking a significant advance in counter-drone defense technology amid escalating global drone warfare threats.

Dexus Industria REIT has agreed to sell its remaining Brisbane Technology Park assets for $155.5 million, marking a strategic pivot to concentrate solely on industrial properties.

Resolution Minerals has received a non-binding $225 million offer from NASDAQ-listed Snow Lake Resources for its Horse Heaven Project in Idaho, signaling potential major shifts for the company’s US operations.

Argent Minerals is fast-tracking its Kempfield Polymetallic Project in NSW, launching diamond drilling and metallurgical testwork to explore early production options and support a scoping study.

FBR Limited has locked in a A$20 million share subscription facility with GEM Global Yield LLC, providing flexible capital to advance its innovative robotics platforms and commercialisation efforts.

Lindian Resources has locked in a US$20 million funding deal and a 15-year offtake agreement with Iluka Resources, underpinning the development of its Kangankunde Rare Earths Project and aligning with Australia’s Eneabba refinery ambitions.

Lindian Resources has locked in a US$20 million funding facility and a 15-year offtake agreement with Iluka Resources, cementing a strategic partnership that advances the Kangankunde Rare Earths Project and links supply to Australia’s Eneabba refinery.

Amplia Therapeutics reports encouraging interim results from its ACCENT trial, with its drug narmafotinib improving progression-free survival and response rates in advanced pancreatic cancer.